256 related articles for article (PubMed ID: 11307925)
21. The mouse rasH2/BHT model as an in vivo rapid assay for lung carcinogens.
Umemura T; Kodama Y; Hioki K; Nomura T; Nishikawa A; Hirose M; Kurokawa Y
Jpn J Cancer Res; 2002 Aug; 93(8):861-6. PubMed ID: 12716462
[TBL] [Abstract][Full Text] [Related]
22. Butylhydroxytoluene (BHT) increases susceptibility of transgenic rasH2 mice to lung carcinogenesis.
Umemura T; Kodama Y; Hioki K; Inoue T; Nomura T; Kurokawa Y
J Cancer Res Clin Oncol; 2001 Oct; 127(10):583-90. PubMed ID: 11599794
[TBL] [Abstract][Full Text] [Related]
23. Twenty-six-week carcinogenicity study of sulfamethoxazole in CB6F1-Tg-rasH2 mice.
Torii M; Itoh F; Yabuuchi K; Ohno K; Kominami G; Hirano K; Tasaki T; Nara H
J Toxicol Sci; 2001 May; 26(2):61-73. PubMed ID: 11429969
[TBL] [Abstract][Full Text] [Related]
24. Extremely weak tumor-promoting effect of troglitazone on splenic hemangiosarcomas in rasH2 mice induced by urethane.
Jin M; Matsumoto S; Dewa Y; Nishimura J; Saekusa Y; Hasumi K; Mitsumori K
Arch Toxicol; 2008 Oct; 82(10):771-7. PubMed ID: 18465119
[TBL] [Abstract][Full Text] [Related]
25. Lung Tumor Induction by 26-week Dermal Application of 1,2-Dichloroethane in CB6F1-Tg rasH2 Mice.
Suguro M; Numano T; Kawabe M; Doi Y; Imai N; Mera Y; Tamano S
Toxicol Pathol; 2017 Apr; 45(3):427-434. PubMed ID: 28421967
[TBL] [Abstract][Full Text] [Related]
26. Carcinogenic susceptibility to N-bis(2-hydroxypropyl)nitrosamine (DHPN) in rasH2 mice.
Okamura M; Moto M; Kashida Y; Machida N; Mitsumori K
Toxicol Pathol; 2004; 32(4):474-81. PubMed ID: 15223773
[TBL] [Abstract][Full Text] [Related]
27. Molecular pathogenesis of transplacentally induced mouse lung tumors.
Miller MS; Leone-Kabler S; Rollins LA; Wessner LL; Fan M; Schaeffer DO; McEntee MF; O'Sullivan MG
Exp Lung Res; 1998; 24(4):557-77. PubMed ID: 9659583
[TBL] [Abstract][Full Text] [Related]
28. High frequency of ras mutations in forestomach and lung tumors of B6C3F1 mice exposed to 1-amino-2,4-dibromoanthraquinone for 2 years.
Hayashi S; Hong HH; Toyoda K; Ton TV; Devereux TR; Maronpot RR; Huff J; Sills RC
Toxicol Pathol; 2001; 29(4):422-9. PubMed ID: 11560247
[TBL] [Abstract][Full Text] [Related]
29. Mice with focal pulmonary fibrosis caused by monocrotaline are insensitive to urethane induction of lung tumorigenesis.
Yasuhara K; Mitsumori K; Shimo T; Onodera H; Takahashi M; Hayashi Y
Toxicol Pathol; 1997; 25(6):574-81. PubMed ID: 9437801
[TBL] [Abstract][Full Text] [Related]
30. The rasH2 transgenic mouse: nature of the model and mechanistic studies on tumorigenesis.
Tamaoki N
Toxicol Pathol; 2001; 29 Suppl():81-9. PubMed ID: 11695564
[TBL] [Abstract][Full Text] [Related]
31. Interlaboratory comparison of short-term carcinogenicity studies using CB6F1-rasH2 transgenic mice.
Takaoka M; Sehata S; Maejima T; Imai T; Torii M; Satoh H; Toyosawa K; Tanakamaru ZY; Adachi T; Hisada S; Ueda M; Ogasawara H; Matsumoto M; Kobayashi K; Mutai M; Usui T
Toxicol Pathol; 2003; 31(2):191-9. PubMed ID: 12696579
[TBL] [Abstract][Full Text] [Related]
32. A 26-week carcinogenicity study of 2-amino-3-methylimidazo[4,5-f]quinoline in rasH2 mice.
Okamura M; Moto M; Muguruma M; Ito T; Jin M; Kashida Y; Mitsumori K
Toxicol Pathol; 2006; 34(2):199-205. PubMed ID: 16537296
[TBL] [Abstract][Full Text] [Related]
33. Lack of susceptibility of transgenic mice carrying the human c-Ha-ras proto-oncogene (rasH2 mice) to phenolphthalein in a 6-month carcinogenicity study.
Koujitani T; Yasuhara K; Usui T; Nomura T; Onodera H; Takagi H; Hirose M; Mitsumori K
Cancer Lett; 2000 May; 152(2):211-6. PubMed ID: 10773414
[TBL] [Abstract][Full Text] [Related]
34. Role of the alveolar type II cell in the development and progression of pulmonary tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the A/J mouse.
Belinsky SA; Devereux TR; Foley JF; Maronpot RR; Anderson MW
Cancer Res; 1992 Jun; 52(11):3164-73. PubMed ID: 1591728
[TBL] [Abstract][Full Text] [Related]
35. Altered expression of connexins in urethane-induced mouse lung adenomas.
Avanzo JL; Mesnil M; Hernandez-Blazquez FJ; da Silva TC; Fukumasu H; Mori CM; Yamasaki H; Dagli ML
Life Sci; 2006 Nov; 79(23):2202-8. PubMed ID: 16926031
[TBL] [Abstract][Full Text] [Related]
36. Map kinase activation correlates with K-ras mutation and loss of heterozygosity on chromosome 6 in alveolar bronchiolar carcinomas from B6C3F1 mice exposed to vanadium pentoxide for 2 years.
Devereux TR; Holliday W; Anna C; Ress N; Roycroft J; Sills RC
Carcinogenesis; 2002 Oct; 23(10):1737-43. PubMed ID: 12376484
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effects of cinnamaldehyde on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung carcinogenesis in rasH2 mice.
Imai T; Yasuhara K; Tamura T; Takizawa T; Ueda M; Hirose M; Mitsumori K
Cancer Lett; 2002 Jan; 175(1):9-16. PubMed ID: 11734331
[TBL] [Abstract][Full Text] [Related]
38. Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes.
Fisher GH; Wellen SL; Klimstra D; Lenczowski JM; Tichelaar JW; Lizak MJ; Whitsett JA; Koretsky A; Varmus HE
Genes Dev; 2001 Dec; 15(24):3249-62. PubMed ID: 11751631
[TBL] [Abstract][Full Text] [Related]
39. Reduction in the number of animals and the evaluation period for the positive control group in Tg.rasH2 short-term carcinogenicity studies.
Shah SA; Paranjpe MG; Atkins PI; Zahalka EA
Int J Toxicol; 2012; 31(5):423-9. PubMed ID: 22988008
[TBL] [Abstract][Full Text] [Related]
40. Nuclear expression of p53, p21 and cyclin D1 is increased in bronchioloalveolar carcinoma.
McDonald JW; Pilgram TK
Histopathology; 1999 May; 34(5):439-46. PubMed ID: 10231419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
